恩瑞格价格

Price: The specification of Enrig is 125mg/28 capsules, and the price is about 2000$. The dosage method is that 1kg of body weight corresponds to 20mg to 40mg of Deferasirox (Enrige). The cost of a normal person weighing 60kg, taking 30mg/kg as an example, the cost of taking Deferasirox for a month is more than 24,000$, which is difficult for ordinary patients to accept.

The original version of deferasirox produced by Novartis in India is 400mg*30 tablets/box, priced at approximately RMB 700; while the generic version of deferasirox produced by Cipla Pharmaceuticals in India is 500mg*30 tablets/box, priced at approximately RMB 500. For more information about Enrige drugs, patients can contact Medical Companion Travel.

Enrig, the generic name is deferasirox dispersible tablets. The ingredient of Enrige is Deferasirox. Enrig is suitable for patients with iron accumulation due to long-term blood transfusion (such as thalassemia or other rare anemias). It is suitable for children over two years old and adults. Enriga should not be used with other iron chelation treatments as the safety of such combined use has not been established. Enrig is contraindicated in patients with creatinine clearance <40mL/min or serum creatinine >2 times the upper limit of normal for the corresponding age; patients with poor general condition, high-risk myelodysplastic syndrome (MDS) or advanced malignant tumors; patients with platelet count <50x109/L.

Deferasirox dispersible tablets () are oral active chelating agents that are highly selective for iron (Fe3+). It is a ligand with 3 protrusions that binds iron with high affinity in a 2:1 ratio. Although deferasirox has a very low affinity for zinc and copper, serum concentrations of these trace metals decreased to varying degrees after administration. The clinical significance of these reductions in metal concentrations is unclear. It should be noted that deferasirox dispersible tablets (Enrige) should be used with caution in patients with reduced liver and kidney function, elderly patients, pregnant and lactating women, and children under 6 years old; children under 2 years old should not use it.